OMNITIDES Trademark

synthesized peptides for medical use, namely, for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; biological reagents for medical use; chemical reagents for medical use, namely, for the detection, measurement and identification of genetic materials; biological tissue cultures, namely, animal tissue cultures for medical purposes; radiopharmaceutical compositions for medical diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides for use in drug discovery of pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; chemical preparations for use in drug discovery for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; pharmaceutical preparations for use in the treatment of medical conditions, namely, suppressing tumors; diagnostic preparations for medical purposes; pharmaceutical preparations in the nature of synthesized peptides for use in drug discovery and pharmaceuticals for the treatment of medical purposes; synthesized proteins and chemical preparations for use in drug discovery and pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain

synthesized peptides for scientific and research use; for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research, product development, and manufacture of pharmaceuticals; chemical reagents for use in evaluating genetic material, namely, the detection, measurement and identification of genetic materials and their compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use; synthesized peptides for scientific and research use, the amino acid sequences of which were identified through or derived from naturally optimized, in vivo generated biological processes; synthesized peptides for scientific and research use, based on peptide sequences originally generated and optimized in vivo

scientific research services in the field of the analysis and synthesis of peptides; scientific research services in the field of the analysis and synthesis of proteins; quality control of peptides used in drug development; advice on quality control of peptides used in drug development; scientific research and development; scientific research and development in the field of immunization; generation, analysis and synthesis workflows for peptides

manufacture of synthetic peptides to the order and specification of others; peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; discovery-to-synthesis of synthetic peptides